This triple peptide blend combines Fragment 176-191 (6mg), Modified GRF 1-29 (3mg), and Ipamorelin (3mg). Mod GRF 1-29 is a stabilized GHRH analog with four amino acid modifications for DPP-4 resistance. Fragment 176-191 provides lipolytic action, while Mod GRF and Ipamorelin stimulate GH release via complementary pathways. Research indicates applications in metabolism, body composition, and tissue regeneration.



Reviews
There are no reviews yet.